Precision Therapeutics: A Wider Aspect of Personalized Medicines

"Precision medicine" will become an intrinsic part of the healthcare system in the near future, and some elaborated features are discussed in this editorial. In recent years, the rise in therapeutic disparities has created significant challenges for "one size fits all" medicines. Modern science has greater potential to deliver more personalized care in terms of medication prescription, patient treatment, health outcomes, and data storage and analysis, while remote communications are becoming regular practice in medical science. Pharmacogenetics and pharmacogenomics have emerged, reshaping precision diagnosis with broad capabilities to depict the whole biocycle in individuals. However, defining gene expression standards remains an area requiring further improvement. Additionally, understanding biological processes, improving diagnostic accuracy, considering ambient environments, optimizing therapies, ensuring standard patient care, enhancing data management, and fostering collaborations among clinicians, researchers, staff, and patients will play key roles in this new era of medicine. Personalized management of gene disorders, cancer, and infectious diseases could help avoid undue drug interactions and adverse events, thereby saving lives. Small-group trials are being conducted based on genetic traits and lifestyle factors that specify certain geographies, while large-population trials are being contextualized with outbreaks of similar pathogenic clades.